Human Molecular Genetics Advance Access originally published online on January 28, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 7 715-725
DOI: 10.1093/hmg/ddh070
Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits




1Human Genetics Division, University of Southampton, School of Medicine, Duthie Building (MP 808), Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK, 2Centre for the Genetics of Cardiovascular Disease, British Heart Foundation Laboratories, The Rayne Building, Royal Free and University College London Medical School, University Street, London WC1E 6JJ, UK and 3Medical Research Council Cardiovascular Research Group, Wolfson Institute of Preventive Medicine, Barts and the London Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
Received November 20, 2003; Accepted January 23, 2004
The IGF2INSTH genomic region has been implicated in various common disorders including the metabolic syndrome, type 2 diabetes and coronary heart disease (CHD). Here we present detailed haplotype analysis of 2743 males 5162 years old in relation to body weight and composition, blood pressure (BP) and plasma triglycerides (TG). Use of the total data set was complicated by the number of loci typed, missing data, multi-allelic markers and continuous trait phenotypes. Different algorithms and subsets of the data were analysed using the programmes haplotype trend regression, haplo.score, evolutionary-based haplotype analysis package and Phase, in conjunction with SPSS. Ten haplotypes designated in frequency order *1(20.0%) to *10(3.4%) represented 89% of all haplotypes. Haplotype *5 protected against obesity. Haplotype *4 carriers exhibited elevated BP and fat mass, haplotype *6 was associated with raised plasma TG levels. Haplotype *8 also showed similar magnitude effects as *4. These cohort trait analyses and detailed haplotypic analyses enable integration with published case data. Haplotypes *4, *6 and *8 are the only INS VNTR class III-bearing haplotypes, although differing in flanking haplotype, whereas *5 displays unique features in all three genes (with significant commonality with type 1 diabetes-predisposition haplotypes). We propose that long repeat insertion in the insulin gene promoter (class III), reported to result in low insulin production, predisposes to the metabolic syndrome features of elevated BP, fat mass or TG level, therefore appearing more frequently in type 2 diabetic, polycystic ovary syndrome and CHD cases. The functional element(s) of *5 for weight-lowering could reside in any of the three genes.
* To whom correspondence should be addressed. Tel: +44 2380794141; Fax: +44 2380794264; Email: santi{at}soton.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Heude, K. K. Ong, R. Luben, N. J. Wareham, and M. S. Sandhu Study of Association between Common Variation in the Insulin-Like Growth Factor 2 Gene and Indices of Obesity and Body Size in Middle-Aged Men and Women J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2734 - 2738. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Devaney, E. P. Hoffman, H. Gordish-Dressman, A. Kearns, E. Zambraski, and P. M. Clarkson IGF-II gene region polymorphisms related to exertional muscle damage J Appl Physiol, May 1, 2007; 102(5): 1815 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. M. Day, S. Rodriguez, J. Kralovicova, P. J. Wood, I. Vorechovsky, and T. R. Gaunt Questioning INS VNTR role in obesity and diabetes: subclasses tag IGF2-INS-TH haplotypes; and -23HphI as a STEP (splicing and translational efficiency polymorphism) Physiol Genomics, December 13, 2006; 28(1): 113 - 113. [Full Text] [PDF] |
||||
![]() |
B. L. Powell, L. Haddad, A. Bennett, N. Gharani, U. Sovio, C. J. Groves, K. Rush, M. J. Goh, G. S. Conway, A. Ruokonen, et al. Analysis of Multiple Data Sets Reveals No Association between the Insulin Gene Variable Number Tandem Repeat Element and Polycystic Ovary Syndrome or Related Traits J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2988 - 2993. [Abstract] [Full Text] [PDF] |
||||


